Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)
Status:
Completed
Trial end date:
2010-09-17
Target enrollment:
Participant gender:
Summary
This study was to compare the safety and efficacy of the preservative-free formulation of
0.0015% MK2452 (tafluprost) and preservative-free 0.5% timolol maleate in patients with
open-angle glaucoma and ocular hypertension. This study was to demonstrate that the
preservative-free formulation of 0.0015% tafluprost is non-inferior to preservative-free 0.5%
timolol maleate.